Internal Medicine, Endocrinology, Diabetes, & Metabolism · Indianapolis, IN
NPI
1023072840
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
541 Clinical Drive, Cl 365
Indianapolis, IN, 46202
Phone (317) 274-0550
Groups this clinician bills Medicare through
Medicare paid, 2024
$38K
728 services
Medicare patients, 2024
195
Average age 70
Drug cost, 2024
$1.5M
3,242 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Paris Roach was code 99214 (office e&m - established), 233 times for 124 patients. In total Paris Roach billed 728 services in 13 codes, and Medicare paid $38K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-03-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 233 | 124 | $88.37 | $21K |
| 95251 Test - Miscellaneous | Office | 196 | 93 | $24.95 | $4,889 |
| 83036 Blood Count | Office | 127 | 87 | $9.52 | $1,209 |
| 99213 Office E&M - Established | Office | 96 | 68 | $59.50 | $5,712 |
| 99204 Office E&M - New | Office | 24 | 24 | $97.39 | $2,337 |
| 99232 Hospital E&M - Subsequent | Facility | 22 | 12 | $57.87 | $1,273 |
By year: 2022 $46K for 951 services; 2023 $42K for 911 services; 2024 $38K for 728 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 127 | 87 | $9.52 | $1,209 |
Medicare prescription drug claims, 2024
In 2024, the drug Paris Roach prescribed most often to Medicare patients was Lantus Solostar (Insulin Glargine,hum.Rec.Anlog), with 235 prescriptions and refills. In total Paris Roach wrote 3,242 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 235 | 633 | 80 | $53K |
| Ozempic Semaglutide | 209 | 398 | 46 | $383K |
| Levothyroxine Sodium Generic | 203 | 562 | 55 | $1,933 |
| Humalog Kwikpen U-100 Insulin Lispro | 165 | 415 | 59 | $74K |
| Metformin Hcl Er Metformin Hcl | 162 | 455 | 45 | $2,260 |
| Mounjaro Tirzepatide | 145 | 159 | 24 | $163K |
| Atorvastatin Calcium Generic | 113 | 305 | 33 | $1,118 |
| Jardiance Empagliflozin | 93 | 194 | 19 | $112K |
| Omnipod 5 Dexg7g6 Pods (Gen 5) Insulin Pump Cart,auto,bt,g6/7 | 86 | 160 | 17 | $95K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 78 | 194 | 33 | $10K |
| Novolog Flexpen Insulin Aspart | 77 | 166 | 34 | $22K |
| Trulicity Dulaglutide | 67 | 123 | 20 | $120K |
| Gabapentin Generic | 65 | 131 | 12 | $719 |
| Metformin Hcl Generic | 60 | 178 | 18 | $535 |
| Testosterone Cypionate Generic | 60 | 86 | 14 | $2,569 |
Brand drugs: 1,751 claims; generic drugs: 1,084 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Paris Roach were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.